Approximately 14–25% of women of reproductive age experience irregular menstrual cycles, which may be associated with hormonal imbalances, painful cramping, and fertility challenges, according to the National Institute of Child Health and Human Development (NICHD).*
Camber Pharmaceuticals is pleased to expand its women’s health portfolio with the launch of clomiphene citrate tablets, USP [KLOE-mih-feen], generic for Clomid®.
Camber’s clomiphene citrate 50 mg tablets, USP are available in cartons containing 10 or 30 tablets.
Clomiphene citrate tablets, USP are indicated only in patients with demonstrated ovulatory dysfunction who meet the conditions described below:
- Patients who are not pregnant.
- Patients without ovarian cysts. Clomiphene citrate should not be used in patients with ovarian enlargement except those with polycystic ovary syndrome.
- Patients without abnormal vaginal bleeding.
- Patients with normal liver function.
To learn more about clomiphene citrate tablets, click here.
*National Institute of Child Health and Human Development
Clomid® is a registered trademark of Cosette Pharmaceuticals, Inc.
